Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Exercise/Conversion of 1,667 URGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 1,667 | n/a |
| Aug 24, 2026 | UroGen Pharma Ltd. (URGN) | Sale | 60,677 | $2.85M |
| Jul 10, 2026 | UroGen Pharma Ltd. (URGN) | Sale | 10,000 | $400.0K |
| Jun 24, 2026 | UroGen Pharma Ltd. (URGN) | Sale | 10,000 | $350.1K |
| Jun 9, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 10,000 | n/a |
| May 11, 2026 | UroGen Pharma Ltd. (URGN) | Sale | 10,000 | $300.0K |
| Feb 5, 2026 | UroGen Pharma Ltd. (URGN) | Sale | 1,844 | $36.3K |
| Feb 3, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 3,333 | n/a |
| Nov 20, 2025 | UroGen Pharma Ltd. (URGN) | Sale | 10,000 | $250.0K |
| Sep 9, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 1,667 | n/a |